DESLORELIN ACETATE |
Synonyms. Tryptal; (D-Trp(6)-pro(9)-NEt)-GNRH; (D-Trp(6)-pro(9))-LHRH; (D-Trp(6)-pro(9))-luteinizing hormone-releasing; (D-Trp6,Pro9-NHEt)LH-RH; (D-Trp6,des-Gly-NH210)-LH-RH; (D-Trp6,des-Gly10)-LH-RH; (Des-Gly10(D-Tro6)-LH-RH; (de-Gly10,D-Trp6,Pro-NHEt)-LH-RH; Somagard; [des-Gly10, D-Trp6]-LH-RH; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-N-ethyl-L- prolinamide; D-Trp LHRH-PEA; D-Trp(sup 6)-pro(sup 9)-N-ethylamide-LHRH; Deslorelin; Deslorelina; Deslorelina; Desloreline; Deslorelinum; GNRH (D-Trp6,pro9-net); |
|
PRODUCT IDENTIFICATION |
CAS RN |
82318-06-7 (acetate); 57773-65-6(ethylamide) |
EINECS RN |
|
FORMULA |
C64H83N17O12 |
MOLE WEIGHT |
1282.46 |
H.S CODE |
2937.90.0000 |
SMILES |
c1(C[C@@H](C(N[C@@H](CO)C(N[C@H](C(N[C@@H](C(=O)N
[C@@H](CC (C) C)C(=O)N[C@H](C(N2CCC[C@H]2C(=O)NCC)=O)
CCCNC(N)= N)Cc2c[nH] c3ccccc23)=O)Cc2ccc(cc2)O)=O) =O)NC
([C@H](Cc2cnc[nH]2 )NC([C@ @H] 2NC (=O)CC2)=O)=O)c2c
([nH]c1) cccc2 |
CLASSIFICATION |
Polypeptide, LHRH agonist |
EXTRA NOTES |
Long-acting analog of LHFSHRH |
PHYSICAL
AND CHEMICAL PROPERTIES |
PHYSICAL STATE. |
white powder |
MELTING POINT |
|
BOILING POINT |
|
DENSITY
|
|
SOLUBILITY IN WATER |
Soluble (soluble in 1% acetic acid) |
SOLVENT SOLUBILITY |
|
VAPOR DENSITY |
|
log P(octanol-water) |
|
VAPOR
PRESSURE |
|
AUTOIGNITION TEMP
|
|
pH |
|
REFRACTIVE INDEX |
|
FLASH
POINT |
|
STABILITY AND REACTIVITY |
STABILITY |
Stable under normal conditions. |
INCOMPATIBLE MATERIALS
|
Strong acids, Strong bases |
POLYMERIZATION |
Has not been reported |
NFPA RATINGS |
Health: 2,Flammability:0, Reactivity: 0 |
EXTERNAL LINKS & GENERAL DESCRIPTION |
Wikipedia
Linking: http://en.wikipedia.org/wiki/Deslorelin
Prostate cancer hormone therapy treatment may use LHRH agonists,
also known as Luteinizing hormone-releasing hormone (LHRH) agonists or
Gonadotropin releasing hormone (GnRH) agonists.
Luteinizing hormone-releasing hormone and Gonadotropin-releasing hormone are
essentially the same chemicals which are released by the hypothalamus when it
detects lowering levels of testosterone. An agonist is a chemical that mimics a naturally-occurring
substance in the body and produces the same physiological effect. The agonist
will occupy the cell receptors of the chemical it is mimicking. An agonist has a
longer biological half-life, meaning the body takes longer to metabolize and
eliminate the agonist. The agonist therefore will occupy a receptor for a longer
period of time. Agonists are sometimes referred to as analogues because they are
inserted beneath the skin where they continuously emit LHRH agonist of GnRH
agonist for a prostate
cancer treatment. LHRH and GnRH agonists are also administered as an
injection that can be performed in a doctor’s office or at home.(http://www.prostate-cancer.com/)
Triptorelin
is a synthetic analogue of gonadorelin
(natural GnRH decapeptide) with amino acid (D-tryptophan) substitution in position 6 to
inhibit rapid degradation for long activity. Used as triptorelin pamoate or
acetate form, triptorelin is used as an antineoplastic
in the palliative treatment of prostatic carcinoma, administered
intramuscularly. Other analogues with two substituents in position 6 and 10
include Buserelin, Deslorelin. Goserelin, Histrelin,
Leuprolide, Nafarelin,
GnRH
agonist
|
|
Product
|
CAS
RN.
|
Deslorelin
|
57773-65-6
|
Goserelin |
65807-02-5 |
Leuprolide acetate |
74381-53-6 |
Leuprolide |
53714-56-0 |
Histrelin |
76712-82-8 |
Lutrelin acetate |
83784-18-3 |
Nafarelin acetate |
86220-42-0 |
Buserelin |
57982-77-1 |
Buserelin acetate |
68630-75-1 |
Triptorelin |
57773-63-4 |
Nafarelin |
76932-56-4 |
GnRH
antagonist
|
|
Product
|
CAS
RN.
|
Detirelix
|
89662-30-6 |
Detirelix acetate |
102583-46-0 |
Abarelix |
183552-38-7 |
Teverelix |
144743-92-0 |
Cetrorelix |
120287-85-6 |
Ganirelix |
124904-93-4 |
Iturelix |
112568-12-4 |
|
SALES
SPECIFICATION
|
APPEARANCE |
white to off-white powder |
IDENTIFICATION
|
Pass
Test (HPLC)
|
PEPTIDE
PURITY
|
98.5%
min
|
AMINO
AID ANALYSIS |
Ser: 0.8 - 1.1 Glx: 0.9 - 1.1 Pro: 0.9 - 1.1 Leu: 0.9 - 1.1 Tyr:
0.9 - 1.1 His: 0.9 - 1.1 Arg: 0.9 - 1.1 Trp: Present |
PEPTIDE
CONTENT |
80.0%
min (N determination)
|
OPTICAL
ROTATION |
-70°
~ -82°(c=0.1, 1% acetic acid) |
WATER |
7.0% max
|
ACETIC
ACID |
12.0%
max
|
TRIFLUOROACETIC
ACID |
0.3% max |
RELATED
SUBSTANCES
|
[D-pGlu1]Deslorelin: 0.5% max [D-His2]Deslorelin: 0.5% max Ser(Ac)4-Deslorelin: 0.5% max Oher
individual impurity: 0.3% max Total impurity: 1.5% max |
MICROBIOLOGICAL
TEST
|
Total viable aerobic count:
100 CFU/g max Bacterial endotoxins: 2 IU/mg max |
RESIDUAL
SOLVENTS |
0.1%
max |
TRANSPORT & REGULATORY INFORMATION |
UN
NO. |
Not
known |
HAZARD CLASS
|
|
PACKING GROUP |
|
SAFETY INFORMATION |
HAZARD OVERVIEW |
May damage fertility or the unborn child. |
GHS
|
|
SIGNAL WORD |
Danger |
PICTOGRAMS |
|
HAZARD
STATEMENTS
|
H360 |
P STATEMENTS |
P201-P308 + P313 |
EC DIRECTIVES |
|
HAZARD CODES |
|
RISK PHRASES |
60 |
SAFETY PHRASES |
53-22-36/37/39-45 |
|